Integrating genomic structural equation modeling and experimental validation to unravel the genetic basis of male genital lichen sclerosus - Report - MDSpire
Advertisement
Integrating genomic structural equation modeling and experimental validation to unravel the genetic basis of male genital lichen sclerosus
Clinical Report: Genetic Underpinnings of Male Genital Lichen Sclerosus
Overview
This study explores the genetic architecture of male genital lichen sclerosus (MGLSc) using genomic structural equation modeling and multi-omics analyses. Key findings include the identification of 43 risk loci and the prioritization of HLA-DPA1 as a significant susceptibility gene.
Background
Male genital lichen sclerosus is a chronic inflammatory disorder that can lead to significant morbidity, including sexual dysfunction. Understanding its genetic basis is crucial for identifying potential therapeutic targets.
Data Highlights
The Genomic-SEM framework generated an indirect GWAS comprising 2,451,318 SNPs for MGLSc, identifying 208 SNPs of genome-wide significance.
Key Findings
43 risk loci and 52 lead SNPs were identified through FUMA annotation.
13 novel SNPs were discovered using a GWAS subtraction strategy.
Four high-confidence variants were highlighted, primarily located in the chromosome 6 major histocompatibility complex region.
HLA-DPA1 was identified as the most significant candidate gene through TWAS.
RT-qPCR confirmed significant downregulation of HLA-DPA1 in MGLSc samples compared to controls (P < 0.0001).
Several MAGMA-prioritized genes were found to be downregulated in MGLSc samples.
Clinical Implications
The identification of genetic risk factors and candidate genes for MGLSc may inform future research.
Conclusion
This study provides insights into the genetic mechanisms underlying MGLSc, emphasizing the role of immune-related loci and highlighting HLA-DPA1 as a key susceptibility gene.
